Abstract
1 In a double-blind crossover study, flurbiprofen produced marked relief of pain which was significantly more than with aspirin and placebo in patients suffering from primary dysmenorrhoea. In contrast, there was no significant difference between the relief of pain obtained with aspirin and placebo. 2 The clinician's overall assessment of efficacy also indicated that flurbiprofen produced better response as compared to aspirin and placebo in these patients with dysmenorrhoea. 3 Both flurbiprofen and aspirin did not produce any apparent adverse effects on blood loss during the menstrual period. 4 In conclusion, the analgesic effect of flurbiprofen seen in this trial establishes the therapeutic usefulness of the drug in the treatment of primary dysmenorrhoea.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson A. B., Haynes P. J., Fraser I. S., Turnbull A. C. Trial of prostaglandin-synthetase inhibitors in primary dysmenorrhoea. Lancet. 1978 Feb 18;1(8060):345–348. doi: 10.1016/s0140-6736(78)91077-2. [DOI] [PubMed] [Google Scholar]
- Blackham A., Owen R. T. Prostaglandin synthetase inhibitors and leucocytic emigration. J Pharm Pharmacol. 1975 Mar;27(3):201–203. doi: 10.1111/j.2042-7158.1975.tb09439.x. [DOI] [PubMed] [Google Scholar]
- Chan W. Y., Hill J. C. Determination of menstrual prostaglandin levels in non-dysmenorrheic and dysmenorrheic subjects. Prostaglandins. 1978 Feb;15(2):365–375. doi: 10.1016/0090-6980(78)90176-4. [DOI] [PubMed] [Google Scholar]
- Crook D., Collins A. J., Bacon P. A., Chan R. Prostaglandin synthetase activity from human rheumatoid synovial microsomes. Effect of 'aspirin-like' drug therapy. Ann Rheum Dis. 1976 Aug;35(4):327–332. doi: 10.1136/ard.35.4.327. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Elder M. G., Kapadia L. Indomethacin in the treatment of primary dysmenorrhoea. Br J Obstet Gynaecol. 1979 Aug;86(8):645–647. doi: 10.1111/j.1471-0528.1979.tb10828.x. [DOI] [PubMed] [Google Scholar]
- Henzl M. R., Buttram V., Segre E. J., Bessler S. The treatment of dysmenorrhea with naproxen sodium: a report on two independent double-blind trials. Am J Obstet Gynecol. 1977 Apr 15;127(8):818–823. doi: 10.1016/0002-9378(77)90111-9. [DOI] [PubMed] [Google Scholar]
- Jones D. E., Halbert D. R., Demers L. M., Fontana J. Prostaglandin levels in endometrial jet wash specimens in patients with dysmenorrhea before and after indomethacin therapy. Prostaglandins. 1975 Dec;10(6):1047–1056. doi: 10.1016/s0090-6980(75)80052-9. [DOI] [PubMed] [Google Scholar]
- Kapadia L., Elder M. G. Flufenamic acid in treatment of primary spasmodic dysmenorrhoea. A double-blind crossover study. Lancet. 1978 Feb 18;1(8060):348–350. doi: 10.1016/s0140-6736(78)91078-4. [DOI] [PubMed] [Google Scholar]
- PICKLES V. R., HALL W. J., BEST F. A., SMITH G. N. PROSTAGLANDINS IN ENDOMETRIUM AND MENSTRUAL FLUID FROM NORMAL AND DYSMENORRHOEIC SUBJECTS. J Obstet Gynaecol Br Commonw. 1965 Apr;72:185–192. doi: 10.1111/j.1471-0528.1965.tb01415.x. [DOI] [PubMed] [Google Scholar]
- Rogers K. D., Reese G. Aspirin for treatment of minor illness in adolescents. Am J Dis Child. 1967 Jul;114(1):55–63. doi: 10.1001/archpedi.1967.02090220061010. [DOI] [PubMed] [Google Scholar]
- Schwartz A., Zor U., Lindner H. R., Naor S. Primary dysmenorrhea: alleviation by an inhibitor of prostaglandin synthesis and action. Obstet Gynecol. 1974 Nov;44(5):709–712. [PubMed] [Google Scholar]
- Vane J. R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol. 1971 Jun 23;231(25):232–235. doi: 10.1038/newbio231232a0. [DOI] [PubMed] [Google Scholar]
- Willman E. A., Collins W. P., Clayton S. G. Studies in the involvement of prostaglandins in uterine symptomatology and pathology. Br J Obstet Gynaecol. 1976 May;83(5):337–341. doi: 10.1111/j.1471-0528.1976.tb00839.x. [DOI] [PubMed] [Google Scholar]